We are live on ! Find out more
ESBF

E S B FINL CORP
ESBF

Delisted

ESBF was delisted on the 10th of February, 2015.

41 hedge funds and large institutions have $31.1M invested in E S B FINL CORP in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 4441 (-3)

12% less capital invested

Capital invested by funds: $35.3M → $31.1M (-$4.22M)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
41
Holders Change
-3
Holders Change %
-6.82%
% of All Funds
1.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
10
Reduced
18
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ESBF Hedge Fund Activity: Q3 2014 in Review

41 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in E S B FINL CORP (ESBF) for Q3 2014, worth a combined $31.1M — down 12% from $35.3M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ESBF and 1 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 10 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $51.6K. The largest seller was Bridgeway Capital Management, cutting an estimated $258K.

  • 41 institutional investors held E S B FINL CORP (ESBF) as of Q3 2014, down from 44 in Q2 2014.
  • Funds reported $31.1M of E S B FINL CORP stock for Q3 2014, down 12% quarter-over-quarter.
  • 1 fund opened new E S B FINL CORP positions in Q3 2014 and 4 closed out, a net change of -3 holders.
  • The largest E S B FINL CORP buyer in Q3 2014 was Tower Research Capital (TRC), an estimated $51.6K added.
  • The largest E S B FINL CORP seller in Q3 2014 was Bridgeway Capital Management, an estimated $258K sold.

Based on aggregated 13F filings for Q3 2014.